No Picture
News

EvoNexus Technology Incubator in Partnership with EMD Performance Materials is Accepting Applications to Admit New Startups

SAN DIEGO–(BUSINESS WIRE)–lt;a href="https://twitter.com/hashtag/EMDPerformanceMaterials?src=hash" target="_blank"gt;#EMDPerformanceMaterialslt;/agt;–EvoNexus Technology Incubator in Partnership with EMD Performance Materials is … […]

No Picture
News

New role for a driver of metastatic cancers

LA JOLLA?Metastatic ovarian, prostate and breast cancers are notoriously difficult to treat and often deadly. Now, Salk Institute researchers have revealed a new role for the CDK12 protein. The findings were published in the print version of Genes &amp… […]

No Picture
News

Rubius cites some preclinical progress; Xencor scores deal with Astellas; Eidos to restate quarterly filings

? Rubius Therapeutics $RUBY has posted some positive ? though preclinical ? study results on its red blood cell tech, saying they were able to track a desired immune response using their drugs.The therapies are designed to increase the flow of T cells … […]

No Picture
News

Progenity Launches First Commercially Available, Custom-Designed, Noninvasive Prenatal Test for Monogenic Diseases

SAN DIEGO–(BUSINESS WIRE)–Progenity, Inc., a privately held biotechnology company, announced today the launch of the Resura? Prenatal Test for Monogenic Disease, the first of its kind, commercially available, customizable, noninvasive prenatal test (… […]

No Picture
News

Turning Point Therapeutics? Kinase Inhibitors Show High Potency against Targeted Oncogene Drivers and Their Mutations

SAN DIEGO–(BUSINESS WIRE)–Turning Point Therapeutics, Inc., a clinical-stage precision oncology company designing and developing novel drugs to address treatment resistance, presented data from four studies at AACR 2019, highlighting potent activity … […]

No Picture
News

Novartis just signed a $1.6B buyout pact with a lead player in an emerging anti-inflammatory field

The executive crew at IFM has just racked up their second blockbuster-sized biotech sale in less than two years.
Not long after Bristol-Myers Squibb stepped up with $300 million in cash to ink a $2.3 billion-plus pact on the oncology applications of th… […]

No Picture
News

Cytonus Therapeutics Announces Poster Presentation at the 2019 American Association for Cancer Research Annual Meeting

SAN DIEGO–(BUSINESS WIRE)–Cytonus Therapeutics Inc., a biotechnology company developing new platforms for delivering biologics, announced today that it will be presenting preclinical data for its Cargocyte? technology platform at the American Associa… […]

No Picture
News

Abzena Expands Management Team: Appoints Campbell Bunce to the Role of Chief Scientific Officer and Bo Adair as Senior Vice President Process and Operations

CAMBRIDGE, England & San Diego–(BUSINESS WIRE)–Abzena, the leading global biologics target to GMP partner research organisation, announced it has appointed Dr Campbell Bunce as Chief Scientific Officer (CSO) and Bo Adair MBA as Senior Vice Presid… […]

No Picture
News

Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues

SAN DIEGO–(BUSINESS WIRE)–Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders … […]

No Picture
News

Illumina and the Lundbeck Foundation GeoGenetics Centre Collaborate to Generate One of the Largest Ancient Genome Datasets to Decode the Genetic Origins and Evolution of Mental Health Issues

SAN DIEGO–(BUSINESS WIRE)–Illumina (NASDAQ:ILMN) and the Lundbeck Foundation GeoGenetics Centre at the University of Copenhagen, Denmark partner to explore the relationship between the evolutionary history of select mental and neurological disorders … […]